International Health
Volume 1, Issue 1 , Pages 61-70 , September 2009

Control of the Neglected Tropical Diseases in sub-Saharan Africa: the unmet needs

  • Alan Fenwick

      Affiliations

    • Schistosomiasis Control Initiative, Imperial College London, St Mary's Campus, Norfolk Place, Paddington, London W2 1PG, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 20 75943418; fax: +44 20 72628140.
  • ,
  • Yaobi Zhang

      Affiliations

    • Schistosomiasis Control Initiative, Imperial College London, St Mary's Campus, Norfolk Place, Paddington, London W2 1PG, UK
  • ,
  • Kari Stoever

      Affiliations

    • Neglected Tropical Disease Control, Sabin Vaccine Institute, Washington, DC, USA

Received 3 March 2009 ,Revised 8 May 2009 ,Accepted 3 June 2009.

References 

  1. Hotez P, Ottesen E, Fenwick A, Molyneux D. The neglected tropical diseases: the ancient afflictions of stigma and poverty and the prospects for their control and elimination. Adv Exp Med Biol. 2006;582:23–33
  2. Hotez PJ, Molyneux DH, Fenwick A, et al. Control of neglected tropical diseases. N Engl J Med. 2007;357(10):1018–1027
  3. UNDP. Human Development Report 2007/2008. United Nations Development Programme; 2009. http://hdr.undp.org/en/reports/global/hdr2007-2008/.[accessed 25 February 2009].
  4. Molyneux DH, Hotez PJ, Fenwick A. Rapid-impact interventions”: how a policy of integrated control for Africa's neglected tropical diseases could benefit the poor. PLoS Med. 2005;2(11):e336
  5. Hotez P, Kamath A. Neglected tropical diseases in sub-Saharan Africa: review of their prevalence, distribution, and disease burden. PLoS Negl Trop Dis. Forthcoming 2009;
  6. Hotez PJ, Molyneux DH, Fenwick A, Ottesen E, Ehrlich Sachs S, Sachs JD. Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria. PLoS Med. 2006;3(5):e102
  7. Hotez PJ, Molyneux DH, Fenwick A, Savioli L, Takeuchi T. A global fund to fight neglected tropical diseases: is the G8 Hokkaido Toyako 2008 Summit ready?. PLoS Negl Trop Dis. 2008;2(3):e220
  8. Mariotti SP, Pascolini D, Rose-Nussbaumer J. Trachoma: global magnitude of a preventable cause of blindness. Br J Ophthalmol. 2009;93(5):563–568
  9. Enk CD. Onchocerciasis--river blindness. Clin Dermatol. 2006;24(3):176–180
  10. Krishna Kumari A, Harichandrakumar KT, Das LK, Krishnamoorthy K. Physical and psychosocial burden due to lymphatic filariasis as perceived by patients and medical experts. Trop Med Int Health. 2005;10(6):567–573
  11. King CH, Dickman K, Tisch DJ. Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet. 2005;365(9470):1561–1569
  12. Stephenson LS. Helminth parasites, a major factor in malnutrition. World Health Forum. 1994;15(2):169–172
  13. Bates I, McKew S, Sarkinfada F. Anaemia: a useful indicator of neglected disease burden and control. PLoS Med. 2007;4(8):e231
  14. Friedman JF, Kanzaria HK, McGarvey ST. Human schistosomiasis and anemia: the relationship and potential mechanisms. Trends Parasitol. 2005;21(8):386–392
  15. Fenwick A, Molyneux D, Nantulya V. Achieving the Millennium Development Goals. Lancet. 2005;365(9464):1029–1030
  16. Ottesen EA. Lymphatic filariasis: Treatment, control and elimination. Adv Parasitol. 2006;61:395–441
  17. Molyneux DH. Elimination of transmission of lymphatic filariasis in Egypt. Lancet. 2006;367(9515):966–968
  18. Fenwick A, Rollinson D, Southgate V. Implementation of human schistosomiasis control: Challenges and prospects. Adv Parasitol. 2006;61:567–622
  19. WHO. African Programmes for Onchocerciasis Control. World Health Organization; 2009. http://www.who.int/blindness/partnerships/APOC/en/.[accessed 23 February 2009].
  20. GAELF. African Programme Review Group: Achievements, constraints, challenges and lessons learnt. Global Alliance to Eliminate Lymphatic Filariasis; 2008. Available: http://www.filariasis.org/resources/africanprg.htm.[accessed 23 February 2009].
  21. Fenwick A. New initiatives against Africa's worms. Trans R Soc Trop Med Hyg. 2006;100(3):200–207
  22. Kumaresan J. Can blinding trachoma be eliminated by 20/20?. Eye. 2005;19(10):1067–1073
  23. Hotez P, Raff S, Fenwick A, Richards F, Molyneux DH. Recent progress in integrated neglected tropical disease control. Trends Parasitol. 2007;23(11):511–514
  24. Hotez P. Mass drug administration and integrated control for the neglected tropical diseases. Clin Pharmacol Ther. 2009 Jun;85(6):659-64. Epub 2009 Mar 25.
  25. WHO. Preventive chemotherapy in human helminthiasis. Geneva: World Health Organization; 2006.
  26. WHO. Demographic and socioeconomic statistics 2006. World Health Organization; 2006. http://data.un.org/Data.aspx?d=WHO&f=inID%3aSDEC01.[accessed 20 January 2009].
  27. Fenwick A. Waterborne infectious diseases--could they be consigned to history?. Science. 2006;313(5790):1077–1081
  28. Augusto G. Distribution of schistosomiasis and soil-transmitted helminthiasis in Mozambique. J Parasitol. Forthcoming 2009;
  29. WHO. Report of the Seventh Meeting of the WHO Alliance for the Global Elimination of Blinding Trachoma. World Health Organization; 2003. http://www.who.int/blindness/publications/GET7-Report-Final.pdf.[accessed 23 February 2009].
  30. Toure S, Zhang Y, Bosque-Oliva E, et al. Two-year impact of single praziquantel treatment on infection in the national control programme on schistosomiasis in Burkina Faso. Bull World Health Organ. 2008;86(10):780–787

PII: S1876-3413(09)00009-6

doi: 10.1016/j.inhe.2009.06.002

International Health
Volume 1, Issue 1 , Pages 61-70 , September 2009